Development of Scalable Synthesis of Chiral Tetralol via Hydrogen Borrowing and Dynamic Kinetic Resolution
Herein, we describe a two-step alkylation and asymmetric transfer hydrogenation telescope process for the synthesis of an enantioenriched substituted tetralol, a key intermediate in the synthesis of active pharmaceutical ingredient udifitimod (BMS-986166). A hydrogen borrowing alkylation catalyzed by an iridium catalyst was developed to replace an asymmetric alkylation that utilized an alkyl iodide with a costly stoichiometric chiral auxiliary under cryogenic conditions. In the following step, construction of the key stereocenter on the tetralin core was enabled by dynamic kinetic resolution using Ru-catalyzed asymmetric transfer hydrogenation. Process optimization allowed for a telescoped process that delivered the chiral alcohol product with high yield, purity, and enantio- and diastereoselectivity as well as controlled levels of residual metal content acceptable for downstream processing.
Authors
- Carolyn S. Wei (ORCID: https://orcid.org/0000-0003-4917-2383)
- Rebecca A. Green (ORCID: https://orcid.org/0000-0002-8492-3122)
- Eric M. Simmons (ORCID: https://orcid.org/0000-0002-3854-1561)
- Jeffrey Nye
- Sloan Ayers (ORCID: https://orcid.org/0000-0003-3562-1846)
- Seung Wook Kim (ORCID: https://orcid.org/0000-0002-7887-7844)
- William Wolf (ORCID: https://orcid.org/0000-0001-6755-8920)
- Candice L. Joe (ORCID: https://orcid.org/0000-0002-7167-2416)
- Michael A. Schmidt (ORCID: https://orcid.org/0000-0002-4880-2083)
- Scott Savage (ORCID: https://orcid.org/0000-0002-7823-0696)
- Maura MacTaggart
Institutions
- Bristol-Myers Squibb (United States) (US)
Publication Details
- Journal
- Organic Process Research & Development
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1021/acs.oprd.5c00090
- Primary Topic
- Asymmetric Hydrogenation and Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00